Melenor

Risedronate sodium, the active ingredient in Melenor, is a bisphosphonate presented as an oral dosage form for oral use. It is indicated for the treatment of osteoporosis, Paget's disease of bone, and glucocorticoid‑induced osteoporosis in appropriate patients.

GNH USA supplies Melenor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melenor is a bisphosphonate used to manage conditions characterized by increased bone resorption. - Osteoporosis: improves bone mineral density and reduces the risk of vertebral and non‑vertebral fractures. - Paget's disease of bone: normalises abnormal bone turnover and alleviates associated pain. - Glucocorticoid‑induced osteoporosis: counteracts steroid‑related bone loss and helps maintain skeletal strength.

Common Side Effects: - Abdominal pain: mild discomfort in the stomach area. - Dyspepsia: indigestion or upset stomach. - Nausea: feeling of queasiness. - Constipation: difficulty passing stools. - Flatulence: excess gas in the gastrointestinal tract. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Osteonecrosis of the jaw: exposed bone in the oral cavity. - Atypical femur fracture: unusual break in the thigh bone. - Severe esophagitis: inflammation or ulceration of the esophagus. - Hypersensitivity reactions: rash, swelling, or anaphylaxis. - Acute phase reaction: fever, muscle pain, or flu‑like symptoms. - Renal impairment: sudden decrease in kidney function.

Before starting Melenor, consider the following precautions: - Assess renal function: evaluate creatinine clearance to ensure safe use. - Ensure adequate calcium and vitamin D intake: supplement if dietary intake is insufficient. - Advise patient to remain upright: stay seated or standing for at least 30 minutes after each dose. - Review gastrointestinal history: avoid use in patients with active esophageal disorders. - Monitor for signs of jaw pain or atypical thigh pain: report promptly to a healthcare professional. - Store at room temperature: keep in the original pack, protect from moisture and light.

Melenor may interact with several medicines; awareness helps optimise safety. Major Interactions (Avoid): - Antacids containing calcium, magnesium, aluminum, or iron: markedly reduce risedronate absorption. - Systemic glucocorticoids: increase risk of bone loss despite therapy. - NSAIDs in patients with ulcer risk: heighten gastrointestinal irritation. Moderate Interactions (Monitor Closely): - Vitamin D analogues: may elevate calcium levels, requiring monitoring. - Loop diuretics: watch electrolyte balance, especially calcium. - Renally toxic agents (e.g., aminoglycosides): assess kidney function regularly.